Suppr超能文献

基因内 CNVs 通过单倍不足机制导致遗传性痉挛性截瘫。

Intragenic CNVs Lead to Hereditary Spastic Paraplegia via a Haploinsufficiency Mechanism.

机构信息

Department of Genetics, Institute of Psychiatry and Neurology, 02-957 Warsaw, Poland.

Institute of Diagnostic Laboratory Medicine, Clinical Chemistry and Pathobiochemistry, Charité-Universitätsmedizin, 10117 Berlin, Germany.

出版信息

Int J Mol Sci. 2024 May 3;25(9):5008. doi: 10.3390/ijms25095008.

Abstract

The most common form of hereditary spastic paraplegia (HSP), SPG4 is caused by single nucleotide variants and microrearrangements in the gene. The high percentage of multi-exonic deletions or duplications observed in SPG4 patients is predisposed by the presence of a high frequency of sequences in the gene sequence. In the present study, we analyzed DNA and RNA samples collected from patients with different microrearrangements in to map gene breakpoints and evaluate the mutation mechanism. The study group consisted of 69 individuals, including 50 SPG4 patients and 19 healthy relatives from 18 families. Affected family members from 17 families carried varying ranges of microrearrangements in the gene, while one individual had a single nucleotide variant in the 5'UTR of . To detect the breakpoints of the gene, long-range PCR followed by sequencing was performed. The breakpoint sequence was detected for five different intragenic deletions and one duplication, revealing -mediated microhomology at breakpoint junctions resulting from non-allelic homologous recombination in these patients. Furthermore, gene expression analysis was performed using patient RNA samples extracted from whole blood. Quantitative real-time PCR tests performed in 14 patients suggest no expression of transcripts with microrearrangements in 5 of them. The obtained data indicate that nonsense-mediated decay degradation is not the only mechanism of hereditary spastic paraplegia in patients with microrearrangements.

摘要

最常见的遗传性痉挛性截瘫(HSP)形式是 SPG4,它是由 基因中的单核苷酸变异和微重排引起的。在 SPG4 患者中观察到的多外显子缺失或重复的高比例是由基因序列中存在高频 序列所导致的。在本研究中,我们分析了来自具有不同 微重排的患者的 DNA 和 RNA 样本,以绘制基因断裂点并评估突变机制。研究组包括 69 人,其中 50 人为 SPG4 患者,19 人为来自 18 个家庭的健康亲属。17 个家族的受影响家庭成员携带 基因中不同范围的微重排,而一个个体在 5'UTR 中存在单个核苷酸变异。为了检测 基因的断裂点,进行了长距离 PCR 测序。对五个不同的内含子 缺失和一个重复进行了检测,结果显示这些患者中的非等位基因同源重组导致了断裂点连接处的 -介导的微同源性。此外,还使用来自全血的患者 RNA 样本进行了 基因表达分析。对 14 名患者进行的定量实时 PCR 测试表明,其中 5 名患者的微重排转录本无表达。所得数据表明,无义介导的衰变降解并非所有具有 微重排的遗传性痉挛性截瘫患者的唯一机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e4b/11084448/2b804fbefc1e/ijms-25-05008-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验